AI
Sunday, February 01, 2015 11:25:40 AM
Science takes a step towards diabetes pill
By Relaxnews
January 30, 2015 11:29 AM
A species of healthy gut bacteria -- tweaked in the science lab -- could be a key player in curing diabetes, according to a new study.
A probiotic pill developed at Cornell University sent glucose levels plummeting by as much as 30 percent in diabetic rats, according to the researchers who took part in the study.
They engineered a strain of lactobacillus -- commonly found in the gut -- that secretes a Glucagon-like peptide 1 (GLP-1).
The science-born probiotic was administered orally to the rats for 90 days, resulting in favorable dips in high blood glucose levels.
Under the influence of the medication, the rats appeared to have normally functioning pancreases, says senior author John March, a biological and environmental engineering professor at Cornell.
Epithelial cells -- capable of secretion and selective absorption -- in the upper intestine converted themselves into cells that acted like glucose-monitoring, insulin-secreting pancreatic beta cells.
"It's moving the center of glucose control from the pancreas to the upper intestine," March describes.
It was tested on healthy rats, and no change in blood glucose levels resulted.
Technology to complete the study was licensed by BioPancreate, a subsidiary of Cortendo AB that's incorporated in Sweden and based in Radnor, Pennsylvania.
The paper was published ( http://tinyurl.com/kwwe8qz ) in the journal Diabetes.
http://news.yahoo.com/science-takes-step-towards-diabetes-pill-162935322.html
By Relaxnews
January 30, 2015 11:29 AM
A species of healthy gut bacteria -- tweaked in the science lab -- could be a key player in curing diabetes, according to a new study.
A probiotic pill developed at Cornell University sent glucose levels plummeting by as much as 30 percent in diabetic rats, according to the researchers who took part in the study.
They engineered a strain of lactobacillus -- commonly found in the gut -- that secretes a Glucagon-like peptide 1 (GLP-1).
The science-born probiotic was administered orally to the rats for 90 days, resulting in favorable dips in high blood glucose levels.
Under the influence of the medication, the rats appeared to have normally functioning pancreases, says senior author John March, a biological and environmental engineering professor at Cornell.
Epithelial cells -- capable of secretion and selective absorption -- in the upper intestine converted themselves into cells that acted like glucose-monitoring, insulin-secreting pancreatic beta cells.
"It's moving the center of glucose control from the pancreas to the upper intestine," March describes.
It was tested on healthy rats, and no change in blood glucose levels resulted.
Technology to complete the study was licensed by BioPancreate, a subsidiary of Cortendo AB that's incorporated in Sweden and based in Radnor, Pennsylvania.
The paper was published ( http://tinyurl.com/kwwe8qz ) in the journal Diabetes.
http://news.yahoo.com/science-takes-step-towards-diabetes-pill-162935322.html
Dan 
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
